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Abstract
Background: The metabolic syndrome (Msyn) affects about 40% of those with hypertension. The Msyn and
hypertension have a common pathophysiology. Exercise is recommended for their treatment, prevention and
control. The influence of the Msyn on the antihypertensive effects of aerobic exercise is not known. We examined
the influence of the Msyn on the blood pressure (BP) response following low (LIGHT, 40% peak oxygen
consumption, VO2peak) and moderate (MODERATE, 60% VO2peak) intensity, aerobic exercise.
Methods: Subjects were 46 men (44.3 ± 1.3 yr) with pre- to Stage 1 hypertension (145.5 ± 1.6/86.3 ± 1.2 mmHg)
and borderline dyslipidemia. Men with Msyn (n = 18) had higher fasting insulin, triglycerides and homeostasis
model assessment (HOMA) and lower high density lipoprotein than men without Msyn (n = 28) (p < 0.01).
Subjects consumed a standard meal and 2 hr later completed one of three randomized experiments separated by
48 hr. The experiments were a non-exercise control session of seated rest and two cycle bouts (LIGHT and
MODERATE). BP, insulin and glucose were measured before, during and after the 40 min experiments. Subjects
left the laboratory wearing an ambulatory BP monitor for the remainder of the day. Repeated measure ANCOVA
tested if BP, insulin and glucose differed over time among experiments in men without and with the Msyn with
HOMA as a covariate. Multivariable regression analyses examined associations among BP, insulin, glucose and the
Msyn.
Results: Systolic BP (SBP) was reduced 8 mmHg (p < 0.05) and diastolic BP (DBP) 5 mmHg (p = 0.052) after
LIGHT compared to non-exercise control over 9 hr among men without versus with Msyn. BP was not different
after MODERATE versus non-exercise control between Msyn groups (p ≥ 0.05). The factors accounting for 17%
of the SBP response after LIGHT were baseline SBP (β = -0.351, r2 = 0.123, p = 0.020), Msyn (β = 0.277, r2 =
0.077, p = 0.069), and HOMA (β = -0.124, r2 = 0.015, p = 0.424). Msyn (r2 = 0.096, p = 0.036) was the only
significant correlate of the DBP response after LIGHT.
Conclusion: Men without the Msyn respond more favorably to the antihypertensive effects of lower intensity,
aerobic exercise than men with the Msyn. If future work confirms our findings, important new knowledge will be
gained for the personalization of exercise prescriptions among those with hypertension and the Msyn.
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Background
Essential hypertension is often associated with a cluster-
ing of multiple risk factors for cardiovascular disease
(CVD) and diabetes mellitus including abdominal adi-
posity, insulin resistance, impaired glucose tolerance, and
dyslipidemia in addition to elevated blood pressure (BP)
[1,2]. This clustering of multiple risk factors is referred to
as the metabolic syndrome (Msyn) and affects about 30%
of the general population [3] and 40% of those with
hypertension [4]. The public health burden of hyperten-
sion [5] and the Msyn [4,6] continues to increase as the
population ages and grows in size.
Participation in habitual physical activity and higher car-
diovascular fitness are inversely related to the prevalence
of hypertension [7] and the Msyn [8]. Lifestyle modifica-
tions are recommended for the prevention, treatment and
control of these conditions, with exercise being a key com-
ponent [7,9,10]. Some of the health benefit ascribed to
aerobic exercise training programs is attributed to the
acute or immediate effects that result from a single exer-
cise session, effects that persist from one to three days
depending on the CVD risk factor targeted [7,11]. The
immediate antihypertensive effects of aerobic exercise,
i.e., postexercise hypotension (PEH), result in BP decreases of
5–7 mm Hg that endure for up to 22 hr after the exercise
session [7,12].
Insulin resistance and hyperinsulinemia are thought to be
primary etiologic agents of hypertension and the Msyn
[13-17]. Multiple mechanisms have been postulated to
explain these associations including activation of the sym-
pathetic nervous system, proliferation of vascular smooth
muscle, altered cation transport, and increased sodium
reabsorption. These derangements increase peripheral
vasculature resistance, impair glucose tolerance, provoke
dylipidemia and endothelial dysfunction, and elevate BP
[18,15-19]. Mancia and colleagues [6] longitudinally
assessed the relationship between the Msyn and early
death among 2,013 adults from 25–74 yr. The associa-
tions they found among the Msyn and death from CVD
and all causes were primarily explained by hypertension
and hyperglycemia. Despite a common underlying patho-
physiology and the importance of exercise in the treat-
ment, prevention and control of hypertension and the
Msyn, the influence of the Msyn on the immediate antihy-
pertensive effects of aerobic exercise among those high BP
is not known.
The primary purpose of this investigation was to examine
the influence of the Msyn on the BP response following a
session of low (LIGHT, 40% peak oxygen consumption,
VO2peak) and moderate (MODERATE, 60% VO2peak)
intensity, aerobic exercise among men with pre- to Stage 1
hypertension. Middle-aged adults with high BP and the
Msyn are at higher CVD risk than those with high BP and
without the Msyn [1,6,20]. Our work indicates that those
more biologically predisposed to CVD, experience greater
BP reductions immediately following a session of aerobic
exercise than those less predisposed to CVD [21,22]. For
these reasons, we hypothesized that men with pre- to
Stage 1 hypertension and the Msyn would manifest PEH
to a greater degree than men without the Msyn. Contrary
to our hypothesis, men with high BP and without the
Msyn responded more favorably to the immediate antihy-
pertensive effects of lower intensity, aerobic exercise than
men with high BP and the Msyn.
Methods
Subjects
Study volunteers were 46 men with pre- to Stage 1 hyper-
tension [systolic BP (SBP) ≥ 130 and < 160 and/or diasto-
lic BP (DBP) ≥ 85 and < 100 mm Hg]. Based upon the
National Cholesterol Education Program criteria [2],
39.1% of these men presented with the Msyn. Volunteers
were physically inactive, had no physical limitations that
would prevent exercise, and did not smoke. Subjects were
excluded if they had SBP ≥ 160 mm Hg and/or DBP ≥ 100
mm Hg, symptomatic atherosclerotic CVD, diabetes mel-
litus, asthma, thyroid dysfunction, pancreatitis, acute ill-
ness and/or were on antidepressant medication. Subjects
signed an informed consent approved by the Institutional
Review Boards of the University of Connecticut and Hart-
ford Hospital.
Medications potentially influencing BP were stopped a
minimum of 4 wk prior to testing. These medications
included antihypertensives, antilipemic agents, aspirin,
nonsteroidal anti-inflammatory agents, nutritional sup-
plements except for a 1-a-day vitamin, cold medications,
and herbal supplements. During the antihypertensive
medication washout period, investigators regularly moni-
tored BP. If the withdrawal of antihypertensive medica-
tion resulted in resting SBP ≥ 160 and/or DBP ≥ 100 mm
Hg, men were excluded from further participation and
resumed their medication regimen.
Procedures
The procedures have been published in part previously
[21-24]. Briefly, subjects participated in an orientation
session to familiarize them with the study and ensure that
their BP met the study criteria. During the orientation ses-
sion, participants were instructed to maintain their nor-
mal diet throughout the study with the exception of a
standard pre-experiment meal. The pre-experiment meal
was consumed 2 hr prior to testing and consisted of 240
ml (1 cup) of low fiber cereal or a choice of one of the fol-
lowing: two slices of white toast, an English muffin, or a
8.9 cm (3.5 in) diameter plain bagel. This meal also
included 120 ml (4 oz) of 2%, 1% or skim milk, and 240BMC Cardiovascular Disorders 2008, 8:12 http://www.biomedcentral.com/1471-2261/8/12
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ml (8 oz) of orange juice. Participants were also asked to
refrain from any caffeinated beverage the morning of the
testing sessions, and to only drink caffeinated [≤ 480 ml
(2 cups)] and alcoholic (≤ 2 drinks/d) beverages in mod-
eration throughout the study. Weight maintenance was
defined as ± 2.25 kg (5.0 lb) of orientation weight and
used as an indication the men were adhering to their nor-
mal dietary patterns during the study. Body weights were
obtained prior to the graded cardiopulmonary exercise
test and each of the three experiments to ensure weight
maintenance.
The orientation session ended with attachment of an
ambulatory BP monitor (Accutracker II automatic nonin-
vasive ambulatory BP monitor, Suntech Medical Instru-
ments Inc., Raleigh, NC) to each subject. The purpose of
this ambulatory BP monitor session was to familiarize
subjects with the unit and ensure their BP met the study
inclusion criteria. Each time the same investigator
attached the ambulatory BP monitor to a subject, a cali-
bration check was done with a mercury sphygmomanom-
eter using a t-tubule as per the manufacture's guidelines.
The calibration check consisted of three test runs to ensure
three successive ambulatory BP measurements were
within 5 mm Hg of ascultatory BP measurements. The
intra-investigator coefficient of variation between the
ambulatory and ascultatory BP measurements made dur-
ing these test runs was 0.7% for SBP and 1.8% for DBP.
The monitor was programmed to record BP and heart rate
(HR) approximately every 20 min. BP and HR were taken
3 times an hour until 2300 hr. Subjects left the laboratory
with instructions to proceed with their typical activities,
not to participate in formal exercise for the remainder of
the day, to leave their arm still when the monitor was
recording, and to return the monitor the following day.
Upon returning the ambulatory BP monitor, a 12 hr fast-
ing venous blood sample was obtained for determination
of insulin, glucose and blood lipid-lipoproteins.
Participants then completed a maximum graded cardiop-
ulmonary exercise stress test used to determine the exer-
cise session workloads. The exercise test was done on a
cycle ergometer (Monark Ergomedic 818E, Stockholm,
Sweden) and consisted of continuous cycling at a cadence
of 60 rev·min-1 with the resistance increased 0.5 kp (30
W) every 2 min until volitional exhaustion. VO2peak was
determined using breath by breath analysis of expired
gases (Sensormedics Vmax 29 Metabolic Chart, Sensor-
Medics Corp., Yorba Linda, CA). HR was recorded contin-
uously with a 12 lead electrocardiogram system. The same
investigator measured BP by auscultation 30 s before the
end of each 2 min stage. Exercise stress test end points
included any combination of the following: an overall rat-
ing of perceived exertion ≥ 18; no increase in oxygen
uptake > 150 ml with increasing exercise intensity; a respi-
ratory exchange ratio > 1.1; achievement of age predicted
maximal HR; and/or inability to maintain pedaling
cadence [25]. At the conclusion of the exercise test, sub-
jects were attached to the same ambulatory monitor as
after the orientation session to further acquaint them with
the equipment.
Subjects completed three, 40 min experiments in random
order on three separate days that were at least 48 hr apart
to avoid acute exercise effects on BP [7,24]. Prior to the
three experiments, a 20 gauge, 32 mm indwelling Teflon
catheter was inserted into the antecubital vein of the right
arm and kept patent with a 0.9% saline solution. Experi-
ments were conducted at the same time of day for a given
subject, and began with a 20 min baseline period. BP
measurements taken during the baseline period were aver-
aged, and this value was used as baseline BP for that exper-
imental session. The three experiments consisted of two
exercise bouts on a cycle ergometer at 40% VO2peak
(LIGHT) and 60% VO2peak (MODERATE) for 30 min,
and a 40 min non-exercise control session of seated rest.
The 30 min exercise sessions were preceded by a 5 min
warm up and followed by a 5 min cool down for a total
40 min of exercise. BP was measured by auscultation dur-
ing the experiments and over the course of 9 hr after the
experiments using the Accutracker II automatic non-inva-
sive ambulatory BP monitor. The average attachment time
was 12:30 pm and the monitor was worn until waking the
next morning.
Blood Sampling and Analysis
Fasting blood samples were drawn into EDTA vacutainer
tubes for insulin, glucose and lipid-lipoproteins determi-
nations. Blood samples were also obtained approximately
2 hr after the standard meal for glucose and insulin deter-
minations at the end of the baseline period, at 30 min of
each 40 min experiment, and at 15 and 45 min after the
experimental sessions while subjects were still in the lab-
oratory but prior to attachment to the ambulatory BP
monitor. Samples were drawn into EDTA vacutainer tubes
and centrifuged at 2500 g and 23°C for 6 min. Plasma
concentrations of insulin were measured in duplicate by
radioimmunoassay using a solid phase, single antibody
assay (Coat-a-Count Insulin, TKIN2, Diagnostic Products
Corporation, Los Angeles, CA) with an intra-assay coeffi-
cient of variation (CV) of 7.0% and inter-assay CV of
7.8%. A multi-level control (CON6 Multivalent Control
Module, Diagnostic Procedures Corporation) was ana-
lyzed during each insulin test run. Plasma glucose concen-
trations were determined in duplicate by an automated
glucose oxidase method (Yellow Springs Instruments,
Model 2003, Yellow Springs, OH). The intra- and inter-
assay CV for the plasma glucose determinations were
2.8% and 3.6%, respectively, at 4.7 mmol·L-1. The home-
ostasis model assessment (HOMA) of insulin resistanceBMC Cardiovascular Disorders 2008, 8:12 http://www.biomedcentral.com/1471-2261/8/12
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was calculated with the formula: [fasting glucose (mg·dL-
1) × insulin (ulU·mL-1)]·22.5-1 [26]. Fasting blood lipids
and lipoproteins were determined by oxidase assays using
colorimetric enzymatic methods (Cobras® Integra™, Roche
Diagnoxtics, Mannheim, Germany). The intra- and inter-
assay CV for the triglyceride assays were 1.6% and 1.9%,
respectively. Low density lipoprotein was calculated with
the Friedewald equation [27].
Sample Size Estimates
Sample size power calculations were conducted assuming
a multivariate approach to analyzing repeated measure BP
data [28]. Based upon our previous work [5,20,24], a
series of power assessments were fit to estimated BP
means and standard deviations for the experimental con-
ditions and Msyn groups. This prior research indicated
adequate power could be expected to detect differences in
the BP change from baseline among the experimental
conditions and Msyn groups with BP hourly change corre-
lations of 0.75 across time. Based upon these assump-
tions, sample sizes of 30 men in each of the Msyn groups
were sufficient to provide adequate power for detecting a
SBP within method effect (non-exercise control, LIGHT
and MODERATE) with a power of 1.000 and a SBP
method by Msyn interaction between Msyn group effect
with a power of 0.600.
Statistical Analyses
Descriptive statistics were obtained on all study parame-
ters. BP was averaged at hourly intervals over the course of
9 hr after the experimental sessions; the time period over
which PEH was noted when the men were awake and
ambulating [24]. Pearson correlations examined relation-
ships among variables that may influence the BP response
to exercise. These variables included age, baseline BP,
body mass index, waist circumference, VO2max, HOMA,
fasting insulin, glucose and lipids and lipoproteins, and
the change in insulin and glucose during the experiments
compared to baseline. Distributions were determined for
these variables using the Kolmogorov-Smirnov test. The
only variables that violated assumptions of normality
were the change in insulin and glucose during the experi-
ments compared to baseline. They were subsequently
transformed into logarithms to improve the skewed distri-
butions. Independent t-tests determined if there were dif-
ferences in subject characteristics among the men with
and without the metabolic syndrome.
Three by two way repeated measures ANCOVA with
HOMA as a covariate determined if BP, insulin and glu-
cose differed over time among experimental conditions
(non-exercise control, LIGHT, MODERATE) among men
without and with the Msyn. Significant interaction effects
were found between BP and men without the Msyn.
Therefore, three way repeated measures ANCOVA then
determined if BP, insulin and glucose differed over time
among experimental conditions (non-exercise control,
LIGHT, MODERATE) within the Msyn groups, and these
results are displayed in Table 2. In order to determine
between Msyn group differences, two by two way repeated
measures ANCOVA determined if BP, insulin and glucose
differed over time among exercise (LIGHT or MODER-
ATE) and non-exercise control among men without and
with the Msyn, and these results are displayed in Figures 1
and 2.
Multivariable regression analyses were performed to
examine what factors correlated with the BP change from
baseline following exercise compared to non-exercise con-
trol over 9 hr. All statistical analyses were done with the
Statistical Package for Social Sciences Base 14.0 for Win-
dows (SPSS Inc., Chicago, IL) with p < 0.05 established as
the level of statistical significance.
Results
Subjects
Participants were 46 overweight, middle-aged Caucasian
men with pre- to Stage 1 hypertension, borderline dyslip-
idemia [2], and low cardiovascular fitness [25] (Table 1).
Of these, 39.1% had the Msyn [2]. Men with the Msyn had
higher fasting insulin, HOMA, total cholesterol/high den-
sity lipoprotein-cholesterol ratio, and triglycerides and
lower high density lipoprotein-cholesterol than men
without the Msyn (Table 1) (p < 0.05).
Blood Pressure Response
Within Msyn Group Effect
Table 2 displays the adjusted BP change from baseline
after the experiments over 9 hr. Among men without the
Msyn, SBP was 6.4 ± 1.9 mmHg lower from baseline after
LIGHT and 6.0 ± 1.6 mmHg lower after MODERATE com-
pared to non-exercise control (p < 0.001). Similarly, DBP
was reduced 3.1 ± 1.5 mmHg from baseline after LIGHT
(p < 0.01) and 2.4 ± 1.3 mmHg (p < 0.05) after MODER-
ATE compared to non-exercise control among men with-
out the Msyn. The post exercise BP response from baseline
was not different after LIGHT and MODERATE versus
non-exercise control among men with the Msyn (p ≥
0.05).
Between Msyn Group Effect
Figures 1 (SBP) and 2 (DBP) display the BP response from
baseline at hourly intervals after exercise (LIGHT and
MODERATE) compared to non-exercise control over 9 hr
among men without and with the Msyn. SBP was 7.5 ± 3.2
mmHg lower from baseline after LIGHT compared to
non-exercise control among men without the Msyn (-6.4
± 1.9 mmHg) versus men with the Msyn (1.1 ± 2.4
mmHg) (Figure 1) (p < 0.05). Similarly, DBP tended to be
4.9 ± 2.5 mmHg lower from baseline after LIGHT com-BMC Cardiovascular Disorders 2008, 8:12 http://www.biomedcentral.com/1471-2261/8/12
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pared to non-exercise control among men without the
Msyn (-3.1 ± 1.5 mmHg) versus men with the Msyn (1.8
± 1.9 mmHg) (Figure 2) (p = 0.052). The post exercise BP
response from baseline was not different after MODER-
ATE compared to non-exercise control between Msyn
groups (p ≥ 0.05).
Insulin and Glucose Response
Figure 3 displays the insulin and glucose response from
baseline during the experiments. Insulin decreased from
baseline during all experiments among the men without
and with the Msyn (p < 0.01). The insulin decrease from
baseline was greater during MODERATE (p < 0.05) but
not during LIGHT (p ≥ 0.05) compared to non-exercise
control among men without and with the Msyn. Glucose
decreased from baseline after exercise compared to non-
exercise control during all experiments among men with-
out and with the Msyn (p < 0.05). However, there was no
difference in the insulin and glucose responses from base-
line during exercise compared to non-exercise control
between Msyn groups (p ≥ 0.05).
Relationships among Blood Pressure and Components of the 
Cardiometabolic Profile
Correlates of the BP change from baseline after LIGHT ver-
sus non-exercise control are shown in Table 3. Factors
accounting for 17% of the SBP response after LIGHT were
baseline SBP (β = -0.351, r2 = 0.123, p = 0.020), Msyn (β
= 0.277, r2 = 0.077, p = 0.069), and HOMA (β = -0.124, r2
= 0.015, p = 0.424). Whereas, Msyn (r2 = 0.096, p = 0.036)
was the only significant correlate of the DBP response
after LIGHT.
Discussion
This study examined the influence of the Msyn on the
immediate antihypertensive effects of aerobic exercise
among men with pre- to Stage 1 hypertension after lower
intensity, aerobic exercise. Among men without the Msyn,
The average adjusted systolic blood pressure change from baseline after LIGHT and MODERATE compared to non-exercise  control at hourly intervals over 9 hr among men without and with the Msyn Figure 1
The average adjusted systolic blood pressure change from baseline after LIGHT and MODERATE compared 
to non-exercise control at hourly intervals over 9 hr among men without and with the Msyn.
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SBP was 8 mm Hg (Figure 1) and DBP 5 mm Hg (Figure
2) lower after LIGHT compared to non-exercise control,
but not after MODERATE over 9 hr. Among men with the
Msyn, BP was not different after exercise and non-exercise
control. Contrary to our hypothesis, men without the
Msyn responded more favorably to the immediate antihy-
pertensive effects of lower intensity, aerobic exercise than
men with the Msyn. The magnitude of the exercise-
induced BP differences we found between Msyn groups
has important clinical and public health considerations
for the personalization of exercise prescriptions for those
with hypertension, 40% of who have the Msyn [4].
The reasons that the men without the Msyn responded
more favorably to the antihypertensive effects of LIGHT
than men with the Msyn are unclear. The vasoactive prop-
erties of insulin are greater with increasing exercise inten-
sity in order to augment the disposal of glucose into the
skeletal muscles [29-31]. However, insulin's vasoactive
role in skeletal muscle perfusion is paradoxical having
both hypotensive, i.e., acutely decreasing vascular resist-
ance and BP; and pro-hypertensive effects, i.e., activation
of renal sodium reabsorption and the sympathetic nerv-
ous system that serve to elevate BP [13,18,32,33]. Our
work [21-24] and that of others [34] supports the notion
that the immediate BP lowering effects of aerobic exercise
are dependent upon the vasodilator-vasoconstrictor bal-
ance imposed on the vasculature by interactions among
genetic predispositions, exercise intensity, and the depres-
sor and pressor actions of BP regulatory hormones such as
catecholamines, renin and insulin.
The paradoxical vasoactive role of insulin on skeletal mus-
cle perfusion would appear to offer a possible explanation
for our finding that men without the Msyn responded to
LIGHT as antihypertensive therapy; whereas the men with
the Msyn did not. For these reasons, we explored in mul-
tivariable regression analyses factors that could account
The average adjusted diastolic blood pressure change from baseline after LIGHT and MODERATE compared to non-exercise  control at hourly intervals over 9 hr among men without and with the Msyn Figure 2
The average adjusted diastolic blood pressure change from baseline after LIGHT and MODERATE compared 
to non-exercise control at hourly intervals over 9 hr among men without and with the Msyn.
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for the post exercise BP response. The insulin and glucose
responses from baseline during exercise did not differ
between the Msyn groups (Figure 3), offering no insight
for our findings. Bursztyn et al. [35] assessed the relation-
ships among insulin, glucose and ambulatory BP before
and after 14 wk of aerobic exercise training performed 3 d/
wk at 60–70% of peak HR among middle aged adults with
hypertension. Despite a marked reduction in insulin and
glucose, ambulatory BP was not different as a result of
exercise training. Their findings are consistent with ours in
that the exercise-induced insulin and glucose responses
appear not to associate with the BP response to aerobic
exercise.
Rheaume and co-investigators studied the effects of acute
moderate intensity (50% VO2peak for 30 min) [36] and
Table 1: Mean (± SEM) fasting physical characteristics of the total sample and among those without and with the metabolic syndrome 
*
Metabolic Syndrome
Variable Total Sample (n = 46) Without (n = 28) With (n = 18)
Age (yr) 44.3 ± 1.3 45.0 ± 1.8 43.2 ± 2.1
Maximum Oxygen Consumption (ml·kg-1·min-1) 30.7 ± 0.9 30.7 ± 1.1 30.6 ± 1.5
Body Mass Index (kg/m2) 29.5 ± 0.7 29.0 ± 1.1 30.4 ± 0.6
Waist Circumference (cm) 102.4 ± 2.1 100.7 ± 3.1 105.0 ± 2.5
Awake Systolic Blood Pressure (mmHg)** 145.5 ± 1.6 145.6 ± 2.2 145.4 ± 2.4
Awake Diastolic Blood Pressure (mmHg) 86.3 ± 1.2 86.9 ± 1.6 85.3 ± 1.3
Insulin (pmol·L-1) 80.0 ± 8.7 59.5 ± 7.0† 111.8 ± 17.1
Glucose(mmol·L-1) 4.5 ± 0.1 4.4 ± 0.1 4.6 ± 0.1
Homeostasis Model Assessment 2.3 ± 0.3 1.7 ± 0.2† 3.3 ± 0.6
Total Cholesterol (TCHOL) (mmol·L-1) 5.0 ± 0.2 4.9 ± 0.2 5.1 ± 0.3
High Density Lipoprotein-Cholesterol (mmol·L-1) 1.10 ± 0.03 1.21 ± 0.04‡ 0.93 ± 0.03
Low Density Lipoprotein-Cholesterol (mmol·L-1) 3.1 ± 0.2 3.2 ± 0.2 3.1 ± 0.3
Total Cholesterol/High Density Lipoprotein Ratio (U) 4.7 ± 0.2 4.2 ± 0.2‡ 5.4 ± 0.2
Triglycerides (mmol·L-1) 1.6 ± 0.2 1.1 ± 0.1‡ 2.4 ± 0.3
* National Cholesterol Education metabolic syndrome diagnosis is established when three of five criteria are present [2]. The fasting criteria 
include: waist circumference > 102 cm; triglycerides ≥ 1.7 mmol·L-1; high density lipoprotein-cholesterol <1.2 mmol·L-1; blood pressure ≥ 130 and/
or 85 mmHg; and glucose > 6.0 mmol·L-1
** Awake blood pressure= ambulatory blood pressure averaged over the time period when men were awake and ambulating, i.e., day time blood 
pressure
†p < 0.01, p < 0.001 ‡ without vs with the Metabolic Syndrome
Table 2: Within group adjusted blood pressure change from baseline after exercise and non-exercise control over 9 hr among the men 
without and with the metabolic syndrome {Mean ± SEM (95% Confidence Interval)}*
SBP Change (mmHg) DBP Change (mmHg)
Non-Exercise 
Control
LIGHT MODERATE Non-Exercise 
Control
LIGHT MODERATE
Without Baseline 
(n = 28)
122.6 ± 3.3 86.4 ± 2.3
Post-Pre 
Experiment 
Change
12.4 ± 1.7 
(9.0,15.8)
6.0 ± 1.7‡§ 
(2.6,9.4)
6.4 ± 1.6‡ 
(3.0,9.7)
0.3 ± 1.2 (-2.1,2.7) -2.8 ± 1.0† (-5.0,-
0.7)
-2.1 ± 1.0** (-
4.0,-0.2)
With Baseline (n = 
28)
126.7 ± 2.6 85.7 ± 1.6
Post-Pre 
Experiment 
Change
9.8 ± 2.1 (5.5,14.1) 10.9 ± 2.1 
(6.6,15.2)
6.9 ± 2.1 (2.7,11.2) -3.7 ± 1.5 (-6.8,-
0.6)
-1.9 ± 1.4 (-
4.6,0.9)
-3.5 ± 1.2(-6.0,-
1.0)
* Baseline = Adjusted blood pressure (Mean ± SEM) of the pre-experiment 20 min period of seated rest for non-exercise control, LIGHT and 
MODERATE. Baseline BP did not differ among experiments so that average baseline BP for the three experiments is presented in Table 2; Post-Pre 
Experiment Change = Hourly blood pressure change after the experiment minus baseline blood pressure averaged over 9 hr.
**p < 0.05, †p < 0.01, ‡p < 0.001 exercise vs non-exercise control; §p < 0.05 exercise vs non-exercise control with vs without the metabolic 
syndrome.
LIGHT, 40% VO2peak; MODERATE, 60% VO2peak.BMC Cardiovascular Disorders 2008, 8:12 http://www.biomedcentral.com/1471-2261/8/12
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Table 3: Correlates of the average blood pressure change from baseline after exercise versus non-exercise control over 9 hr.
Blood Pressure Change Predictors β t Partial r r2 p
LIGHT Versus Non-Exercise Control
Systolic Blood Pressure Baseline Systolic Blood Pressure -0.233 -2.426 -0.351 0.123 0.020
Metabolic Syndrome 5.807 1.869 0.277 0.077 0.069
HOMA -0.645 -0.807 -0.124 0.015 0.424
Model Summary 0.474 0.170 0.013
Diastolic Blood Pressure Baseline Diastolic Blood Pressure -0.045 -0.361 -0.056 0.003 0.720
Metabolic Syndrome 4.852 1.918 0.284 0.081 0.062
HOMA -0.101 -0.154 -0.024 0.001 0.878
Model Summary 0.315 0.035 0.216
MODERATE Versus Non-Exercise Control
Systolic Blood Pressure Baseline Systolic Blood Pressure -0.131 -1.428 -0.215 0.046 0.161
Metabolic Syndrome 2.628 0.928 0.142 0.020 0.358
HOMA 0.062 0.084 0.013 0.000 0.934
Model Summary 0.028 0.014 0.315
Diastolic Blood Pressure Baseline Diastolic Blood Pressure -0.055 -0.500 -0.077 0.006 0.620
Metabolic Syndrome 2.571 1.111 0.169 0.029 0.273
HOMA 0.502 0.829 0.127 0.016 0.412
Model Summary 0.288 0.018 0.300
HOMA = homeostasis model assessment
The average insulin and glucose change from baseline during the experiments among men without and with the Msyn Figure 3
The average insulin and glucose change from baseline during the experiments among men without and with 
the Msyn. LIGHT = 40% VO2peak; MODERATE = 60% VO2peak.
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prolonged, vigorous intensity (70% VO2peak for 90 min)
[37] aerobic exercise on insulin sensitivity as assessed by
an intravenous glucose tolerance test among men with
elevated BP for up to 4 hr after exercise. They found that
insulin sensitivity was increased after moderate but not
vigorous intensity exercise. Rheaume et al. [36,37] par-
tially attributed these differential exercise intensity to a
higher adrenergic response and greater vasoconstrictor
actions after vigorous than moderate intensity exercise.
The results of Rheaume et al. [36,37] provide insight into
why men without the Msyn but not men with the Msyn
lowered BP following exercise in our study. As shown in
Table 1, men without the Msyn had increased insulin sen-
sitivity (i.e., lower HOMA) compared to men with the
Msyn (Table 1). Among men without the Msyn, as insulin
sensitivity increased, the decreases in SBP from baseline
after LIGHT (r = 0.403, r2 = .162, p = 0.019) and MODER-
ATE (r = 0.440, r2 = 0.193, p = 0.033) were greater. Fur-
thermore, in multivariable regression analyses, HOMA
remained a significant correlate of the SBP response fol-
lowing LIGHT (Table 3). In contrast, among men with the
Msyn, as insulin sensitivity decreased, the decrease in SBP
from baseline after LIGHT (r = -0.464, r2 = 0.215, p =
0.053) tended to be greater but not after MODERATE (r =
-0.277, r2 = 0.077, p = 0.266). The antihypertensive bene-
fits of lower intensity, aerobic exercise appeared to result
from improved insulin sensitivity and a more favorable
vasodilator-vasoconstrictor balance following exercise
among men without the Msyn compared to men with the
Msyn. Future investigation is needed to more precisely
establish the mechanisms for our observations.
This study has several limitations. Post-prandial plasma
insulin and glucose assessments were measured only in
the laboratory and not under ambulatory conditions in an
attempt to minimize experimental intrusions that could
affect the BP measurements and for reasons of subject
convenience. However, we examined the relationships
among BP, insulin and glucose in the laboratory (data not
shown) and found the findings to be strikingly similar to
those reported in this paper over 9 hr. We did not perform
an oral glucose tolerance test to determine insulin sensi-
tivity during and after exercise while subjects were still in
the laboratory. It remains possible that a more sensitive
measure of insulin sensitivity than HOMA may have
shown different associations with post exercise BP. Lastly,
we attempted to control for the confounding influence of
diet on the baseline plasma insulin and glucose concen-
trations of our subjects prior to the experiments by
instructing them to consume a standard meal 2 hr prior to
any testing. However, we relied upon self-report to verify
dietary compliance which does not ensure the instruc-
tions were followed.
Conclusion
Men without the Msyn appear to respond more favorably
to the immediate antihypertensive effects of lower inten-
sity, aerobic exercise than men with the Msyn. Factors
accounting for this result were baseline BP, the Msyn and
HOMA, explaining 17% of the variability in the SBP
response after LIGHT. Future work is needed to confirm
our findings in a larger, more ethnically diverse sample of
men and women to elucidate reasons for the differential
impact that the Msyn has on the antihypertensive effects
of aerobic exercise. Considering the significant public
health burden of hypertension and the Msyn and the
importance of exercise in their prevention, treatment and
control, results from such studies could yield important
new knowledge for the personalization of exercise pre-
scriptions among those with hypertension and the Msyn.
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